General Information of the Compound
| Compound ID |
CP0850603
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-N-{1-[2-(Biphenyl-2-yloxy)ethyl]piperidin-4-yl}-quinoline-sulfonamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C28H29N3O3S
|
||||||||||||||||||
| Molecular Weight |
487.625
|
||||||||||||||||||
| Canonical SMILES |
O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)CC1)c1cccc2ncccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C28H29N3O3S/c32-35(33,28-14-6-12-26-25(28)11-7-17-29-26)30-23-15-18-31(19-16-23)20-21-34-27-13-5-4-10-24(27)22-8-2-1-3-9-22/h1-14,17,23,30H,15-16,18-21H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
RXNFFABQLHFLBY-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT00941, 5-hydroxytryptamine receptor 7